Western Wealth Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $333K | Buy |
3,889
+380
| +11% | +$37.2K | 0.01% | 752 |
|
|
2026
Q2 | $363K | Sell |
3,509
-4
| -0.1% | -$357 | 0.01% | 768 |
|
|
2026
Q1 | $252K | Sell |
3,513
-227
| -6% | -$17.5K | 0.01% | 852 |
|
|
2025
Q4 | $297K | Buy |
3,740
+669
| +22% | +$52.7K | 0.01% | 663 |
|
|
2025
Q3 | $232K | Sell |
3,071
-49
| -2% | -$3.36K | 0.01% | 691 |
|
|
2025
Q2 | $215K | Sell |
3,120
-218
| -7% | -$14.3K | 0.01% | 670 |
|
|
2025
Q1 | $226K | Buy |
+3,338
| New | +$200K | 0.02% | 616 |
|
|
2024
Q4 | – | Sell |
-4,593
| Closed | -$289K | – | 761 |
|
|
2024
Q3 | $289K | Sell |
4,593
-1,614
| -26% | -$94.2K | 0.02% | 608 |
|
|
2024
Q2 | $367K | Sell |
6,207
-11,134
| -64% | -$696K | 0.03% | 445 |
|
|
2024
Q1 | $1.38M | Sell |
17,341
-17,195
| -50% | -$1.31M | 0.11% | 179 |
|
|
2023
Q4 | $2.73M | Sell |
34,536
-2,412
| -7% | -$172K | 0.2% | 106 |
|
|
2023
Q3 | $2.58M | Buy |
36,948
+1,797
| +5% | +$127K | 0.22% | 96 |
|
|
2023
Q2 | $2.43M | Sell |
35,151
-2,440
| -6% | -$174K | 0.21% | 105 |
|
|
2023
Q1 | $2.79M | Buy |
37,591
+77
| +0.2% | +$6.46K | 0.26% | 90 |
|
|
2022
Q4 | $3.5M | Sell |
37,514
-26,714
| -42% | -$2.58M | 0.36% | 56 |
|
|
2022
Q3 | $6.12M | Buy |
64,228
+1,035
| +2% | +$102K | 0.35% | 56 |
|
|
2022
Q2 | $5.88M | Sell |
63,193
-260
| -0.4% | -$25.4K | 0.34% | 65 |
|
|
2022
Q1 | $6.42M | Buy |
63,453
+36,577
| +136% | +$3.84M | 0.31% | 68 |
|
|
2021
Q4 | $2.77M | Buy |
+26,876
| New | +$2.48M | 0.27% | 82 |
|
|
2021
Q2 | $3.19M | Buy |
38,143
+10,534
| +38% | +$863K | 0.33% | 66 |
|
|
2021
Q1 | $2.08M | Sell |
27,609
-4,590
| -14% | -$334K | 0.28% | 80 |
|
|
2020
Q4 | $2.2M | Buy |
32,199
+4,178
| +15% | +$272K | 0.32% | 75 |
|
|
2020
Q3 | $1.64M | Sell |
28,021
-5,563
| -17% | -$346K | 0.27% | 94 |
|
|
2020
Q2 | $2.18M | Buy |
33,584
+71
| +0.2% | +$4.47K | 0.4% | 48 |
|
|
2020
Q1 | $1.99M | Buy |
33,513
+4,509
| +16% | +$301K | 0.46% | 48 |
|
|
2019
Q4 | $2.16M | Buy |
29,004
+279
| +1% | +$19.6K | 0.33% | 70 |
|
|
2019
Q3 | $1.82M | Sell |
28,725
-20,344
| -41% | -$1.21M | 0.38% | 60 |
|
|
2019
Q2 | $2.87M | Buy |
49,069
+23,387
| +91% | +$1.26M | 0.38% | 52 |
|
|
2019
Q1 | $1.38M | Buy |
25,682
+17,071
| +198% | +$1.05M | 0.31% | 81 |
|
|
2018
Q4 | $573K | Buy |
+8,611
| New | +$643K | 0.15% | 160 |
|
Other funds holding CVS
Western Wealth Management's CVS Position: Q3 2026 in Review
Western Wealth Management increased its CVS Health (CVS) stake by 11% in Q3 2026, buying an estimated $37.2K and bringing the position to 3,889 shares worth $333K. The position accounts for 0.01% of the portfolio, ranked #752.
Western Wealth Management first reported a position in CVS in Q4 2018 and has held it in 30 quarters since. The position peaked at $6.42M in Q1 2022. 1,987 funds tracked by Wall St. Rank hold CVS as of Q3 2026.
- Western Wealth Management held 3,889 shares of CVS Health worth $333K as of Q3 2026.
- Western Wealth Management bought 380 CVS Health shares in Q3 2026, an estimated $37.2K.
- CVS Health made up 0.01% of Western Wealth Management's portfolio in Q3 2026, its #752 holding.
- Western Wealth Management first reported a position in CVS Health in Q4 2018 and has held it in 30 quarters since.
- Western Wealth Management's CVS Health position peaked at $6.42M in Q1 2022.
- 1,987 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.
Based on Western Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.